Gene · 6103
Papers1,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Newer therapeutic options for inherited retinal diseases: Gene and cell replacement therapy. | Indian J Ophthalmol | 2022 | 35791112 | PubTator, text mining | PubMed |
| The Role of Lipid Metabolism in Gastric Cancer. | Front Oncol | 2022 | 35785165 | PubTator, text mining | PubMed |
| Patients with Retinitis Pigmentosa May Have a Higher Risk of Developing Open-Angle Glaucoma. | J Ophthalmol | 2022 | 35783342 | PubTator, text mining | PubMed |
| Protein-protein interaction and non-interaction predictions using gene sequence natural vector. | Commun Biol | 2022 | 35780196 | PubTator, text mining | PubMed |
| Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan. | Front Immunol | 2022 | 35769485 | PubTator, text mining | PubMed |
| Characterization of Double-Strand Break Repair Protein Ku80 Location Within the Murine Retina. | Invest Ophthalmol Vis Sci | 2022 | 35737378 | PubTator, text mining | PubMed |
| A BIRC5High COD1Low Cancer Tissue Phenotype Indicates Poorer Prognosis of Metastatic Breast Cancer Patients. | Cancer Inform | 2022 | 35734521 | PubTator, text mining | PubMed |
| Identification of Biomarkers Associated With CD4+ T-Cell Infiltration With Gene Coexpression Network in Dermatomyositis. | Front Immunol | 2022 | 35711463 | PubTator, text mining | PubMed |
| Likely pathogenic structural variants in genetically unsolved patients with retinitis pigmentosa revealed by long-read sequencing. | J Med Genet | 2022 | 35710107 | PubTator, text mining | PubMed |
| Tolerance of Senecavirus A to Mutations in Its Kissing-Loop or Pseudoknot Structure Computationally Predicted in 3' Untranslated Region. | Front Microbiol | 2022 | 35707163 | PubTator, text mining | PubMed |
| Axial Length Distributions in Patients With Genetically Confirmed Inherited Retinal Diseases. | Invest Ophthalmol Vis Sci | 2022 | 35704304 | PubTator, text mining | PubMed |
| Chronic Granulomatous Disease: an Updated Experience, with Emphasis on Newly Recognized Features. | J Clin Immunol | 2022 | 35696001 | PubTator, text mining | PubMed |
| Development of PD3 and PD3-B for PDEδ inhibition to modulate KRAS activity. | J Enzyme Inhib Med Chem | 2022 | 35695156 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses. | Clin Ophthalmol | 2022 | 35685379 | PubTator, text mining | PubMed |
| Breakthroughs and Applications of Organ-on-a-Chip Technology. | Cells | 2022 | 35681523 | PubTator, text mining | PubMed |
| Clinical exome sequencing for inherited retinal degenerations at a tertiary care center. | Sci Rep | 2022 | 35672425 | PubTator, text mining | PubMed |
| Panel-based next-generation sequencing identifies novel mutations in Bulgarian patients with inherited retinal dystrophies. | Mol Genet Genomic Med | 2022 | 35656873 | PubTator, text mining | PubMed |
| The first reported case of a deletion of the entire RPGR gene in a family with X-linked retinitis pigmentosa. | Ophthalmic Genet | 2022 | 35652150 | PubTator, text mining | PubMed |
| Bioinformatics approach reveals the critical role of the NOD-like receptor signaling pathway in COVID-19-associated multiple sclerosis syndrome. | J Neural Transm (Vienna) | 2022 | 35648256 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6103/papers?page=23